Sr. Director, Corporate Controller
Amy Chen is the Corporate Controller at Kriya Therapeutics. Prior to joining Kriya, Ms. Chen worked at Jazz Pharmaceuticals as the Director of Accounting, supporting all aspects of the company’s US accounting operations and related SOX compliance. Before Jazz, she was the Assistant Controller at Natera, where she played a key role in the company’s accounting readiness for its initial S-1 filing. Ms. Chen also worked at JDSU, a high tech company, with roles in both technical accounting and BU finance. Ms. Chen started her career in public accounting with Deloitte and subsequently Ernst & Young, serving both public and private audit clients across various industries. She is a Certified Public Accountant actively licensed in the state of California.
Ms. Chen received her master’s of science in Economics from Southern Illinois University at Carbondale and her master’s of Accountancy from the University of Georgia. She received her undergraduate degree in Economics from Zhongnan University of Economics of Law in China.